In addition, oxidative stress (measured as MDA) was reduced, liver function markers (ALT, AST) were restored to 50 to 90% of control levels, hepatic protein synthesis was increased, levels of urea/uric acid and creatinine were reduced, and diabetes-associated liver and renal damage were alleviated. This evidence concerns the gene GPT and diabetes mellitus.